ADM and Alzheimer disease: Furthermore, adipocytokines may contribute as a diagnostic tool to a multimarkerstrategy in AD simultaneously evaluating biomarkers such as endothelin-1, atrialnatriureticpeptide, and adrenomedullin with immune modulating, metabolic, andvascular characteristics [44].